FilingReader Intelligence
Boya Bio's controlling shareholder increases stake through market purchases
May 9, 2025 at 05:08 AM UTC•By FilingReader AI
China Resources Pharmaceutical Holdings has increased its stake in Boya Bio-Pharmaceutical Group (SZSE:300294) by acquiring 6,050,900 shares through the Shenzhen Stock Exchange between November 8, 2024, and May 7, 2025. The transaction brings China Resources Pharmaceutical Holdings' total ownership to 153,691,453 shares, representing 30.4793% of Boya Bio's total share capital. China Resources Pharmaceutical Holdings retains its controlling shareholder status.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Boya Bio-Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime